The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Experiences of patients with bladder cancer: A comparison of urban and rural areas.
 
Lydia Makaroff
Stock and Other Ownership Interests - Aila Biotech Ltd (I)
Honoraria - Bayer
Consulting or Advisory Role - Astellas Pharma (Inst); Bristol Myers Squibb (Inst); Imcyse (I); Janssen (Inst); Merck Serono (Inst); MSD (Inst); Pfizer (Inst); Roche (Inst); Seagen (Inst); Soffinova (I)
Research Funding - Arquer Diagnostics (Inst)
Travel, Accommodations, Expenses - Astellas Pharma; Merck; Merck; MSD; Pfizer; Pfizer
 
Alex Filicevas
Other Relationship - World Bladder Cancer Patient Coalition
 
Patrick J. Hensley
No Relationships to Disclose
 
Ashish M. Kamat
Honoraria - AstraZeneca (I); Tesaro (I)
Consulting or Advisory Role - Arquer Diagnostics; Asieris Pharmaceuticals; Astellas Pharma; Biological Dynamics; Bristol-Myers Squibb; CG Oncology; Cystotech; Eisai; EnGeneIC; FerGene; Imagin Medical; Imvax; Incyte; Janssen; Medac; Merck; Nonagen Bioscience; Pfizer; Photocure; Protara Therapeutics; Roche; Seagen; Sesen Bio; Theralase; TMC Innovation; Urogen pharma; US Biotest
Research Funding - Adolor; Bristol-Myers Squibb; FKD Therapies; Heat Biologics; Janssen/Taris; Merck; NIH; Patient-Centered Outcomes Research Institute (PCORI); Photocure; Seagen; SWOG; Taris BioMedical; The Leo & Anne Albert Institute for Bladder Cancer Care and Research (AIBCCR)
Patents, Royalties, Other Intellectual Property - Patent: CyPRIT (Cytokine Predictors of Response to Intravesical Therapy) joint with UT MD Anderson Cancer Center
Other Relationship - European Urology Oncology; International Bladder Cancer Group (IBCG); International Bladder Cancer Network; Journal of Urology; UroToday